For general practitioners, the study findings reaffirm the RACGPs and TGAs recent statements advising prescribers to prioritise the use of semaglutide for patients with T2D who are either current users or are previous users and for whom other glucose-lowering medications, including sulfonylureas, dipeptidyl peptidase 4 inhibitors and sodiumglucose cotransporter 2 inhibitors (Table 1), are unsuitable due to refractory or worsening glycaemic control, intolerance or contraindication
Eden does not sell medications or set drug prices
Individuals should refrain from unauthorized off-label use, as it poses significant risks [Reference Eguale, Buckeridge, Verma, Winslade, Benedetti and Hanley48]
Other Ingredients: Hypromellose (cellulose capsule), Microcrystalline Cellulose, Magnesium Stearate (vegetable source) and Silicon Dioxide
GLP-1 Agonist for Leptin Resistance: UK Guidance and Treatment Options GLP-1 receptor agonists are a class of medications licensed in the UK for type 2 diabetes and, in some formulations, weight management
Comparison of TESAMORELIN and CJC 1295 This table provides a clear comparison of TESAMORELIN and CJC 1295, highlighting their key attributes, benefits, recommended dosages, and safety profiles